[Cytotoxic antibodies in multiple sclerosis]. 1987

L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard

Serum cold cytotoxic activities against allocells: total lymphocytes, B lymphocytes and monocytes were detected in 12 of 21 multiple sclerosis (MS) patients at 15 degrees C using a microcytotoxicity technique. Cytotoxic activity was found at 37 degrees C in certain MS patients. This activity was weak or absent in non MS patients and in healthy controls. Tests with autocells were positive in 6 MS patients. Cerebrospinal fluid cytotoxic activity was found in MS as well as in non-MS diseases; at 37 degrees C CSF produced lysis of monocytes in the absence of complement. No correlation was found between cytotoxic activity and parameters of clinical disease. Our results suggest that there may be a wide variety of cytotoxic antibodies in MS. Their significance is unknown; it may be that they have an effect on certain lymphocyte subsets as it has been suggested in other diseases.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard
June 1976, Fortschritte der Medizin,
L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard
May 1979, Journal of the neurological sciences,
L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard
January 1993, Neurologia i neurochirurgia polska,
L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard
January 2008, Neuro-degenerative diseases,
L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard
September 1984, Deutsche medizinische Wochenschrift (1946),
L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard
January 1978, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale,
L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard
January 1970, British medical journal,
L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard
July 1982, Italian journal of neurological sciences,
L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard
January 1977, Clinical immunology and immunopathology,
L Rumbach, and M M Tongio, and S Mayer, and C Marescaux, and J M Warter, and M Collard
December 1995, Neurology,
Copied contents to your clipboard!